# Frauke Zipp

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/frauke-zipp/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,998 |
| Field | Multiple Sclerosis Research Studies |
| h-index | 85 |
| i10-index | 317 |
| Last Known Institution | Johannes Gutenberg University Mainz |
| OpenAlex ID | https://openalex.org/A5083000991 |
| ORCID iD | https://orcid.org/0000-0002-1231-1928 |
| Works | 538 |

## Researcher papers

- [Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis](https://scholariq.org/papers/genetic-risk-and-a-primary-role-for-cell-mediated-immune-mechanisms-in-multiple/)
- [Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis](https://scholariq.org/papers/analysis-of-immune-related-loci-identifies-48-new-susceptibility-variants-for/)
- [Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility](https://scholariq.org/papers/multiple-sclerosis-genomic-map-implicates-peripheral-immune-cells-and-microglia/)
- [Multiple Sclerosis Severity Score](https://scholariq.org/papers/multiple-sclerosis-severity-score/)
- [ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis](https://scholariq.org/papers/ectrims-ean-guideline-on-the-pharmacological-treatment-of-people-with-multiple/)
- [Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database](https://scholariq.org/papers/comprehensive-research-synopsis-and-systematic-meta-analyses-in-parkinson-s/)
- [DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis](https://scholariq.org/papers/dna-methylation-as-a-mediator-of-hla-drb1-15-01-and-a-protective-variant-in/)
- [TNF-related apoptosis inducing ligand (TRAIL) as a potential response marker for interferon-beta treatment in multiple sclerosis](https://scholariq.org/papers/tnf-related-apoptosis-inducing-ligand-trail-as-a-potential-response-marker-for/)
- [Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)](https://scholariq.org/papers/multiple-sclerosis-therapy-consensus-group-mstcg-position-statement-on-disease/)
- [Network-Based Multiple Sclerosis Pathway Analysis with GWAS Data from 15,000 Cases and 30,000 Controls](https://scholariq.org/papers/network-based-multiple-sclerosis-pathway-analysis-with-gwas-data-from-15-000/)

## Researcher topics

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Neuroinflammation and Neurodegeneration Mechanisms](https://scholariq.org/topics/neuroinflammation-and-neurodegeneration-mechanisms/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Peripheral Neuropathies and Disorders](https://scholariq.org/topics/peripheral-neuropathies-and-disorders/)

## Researcher university

- [Johannes Gutenberg University Mainz](https://scholariq.org/institutions/johannes-gutenberg-university-mainz/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.